We are live on ! Find out more
SRC

Shufro Rose & Co Portfolio holdings

AUM $1.47B
1-Year Est. Return 19.38%
This Fund
S&P 500
This Quarter Est. Return
-1.26%
1 Year Est. Return
+19.38%
3 Year Est. Return
+47.49%
5 Year Est. Return
+55.37%
10 Year Est. Return
+200.77%
AUM
$1.29B
AUM Growth
+$61.5M
Cap. Flow
+$11.7M
Cap. Flow %
0.91%
Top 10 Hldgs %
37.9%
Holding
333
New
17
Increased
60
Reduced
147
Closed
33

Sector Composition

Rank Sector Weight
1 Technology 20.24%
2 Financials 8.46%
3 Healthcare 7.38%
4 Consumer Discretionary 6.37%
5 Industrials 3.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IBM icon
26
IBM
IBM
$213B
$16.1M 1.24%
73,168
-144
-0.2% -$32.1K
OPLN
27
Openlane
OPLN
$4.28B
$15.3M 1.18%
770,435
-4,390
-0.6% -$81K
GLD icon
28
SPDR Gold Trust
GLD
$131B
$15.2M 1.18%
62,913
+169
+0.3% +$41.5K
QUAL icon
29
iShares MSCI USA Quality Factor ETF
QUAL
$45.7B
$13.2M 1.02%
73,964
+9,902
+15% +$1.8M
NVDA icon
30
NVIDIA
NVDA
$4.6T
$12.8M 0.99%
95,029
+61,168
+181% +$8.43M
COHR icon
31
Coherent
COHR
$43.4B
$12M 0.93%
127,007
-25,711
-17% -$2.57M
VCSH icon
32
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
$11.6M 0.9%
148,766
+51,785
+53% +$4.06M
AMGN icon
33
Amgen
AMGN
$209B
$10.5M 0.81%
40,432
-1,304
-3% -$387K
BSCP
34
DELISTED
Invesco BulletShares 2025 Corporate Bond ETF
BSCP
$10.5M 0.81%
508,556
-20,284
-4% -$419K
BSCT icon
35
Invesco BulletShares 2029 Corporate Bond ETF
BSCT
$2.91B
$10.4M 0.81%
569,423
+416,623
+273% +$7.71M
VCIT icon
36
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.2B
$9.74M 0.75%
121,316
+103,853
+595% +$8.48M
VTI icon
37
Vanguard Total Stock Market ETF
VTI
$646B
$9.45M 0.73%
32,606
+16,965
+108% +$4.95M
NVDA icon
38
PUT
NVIDIA
NVDA
$4.6T
0
VBR icon
39
Vanguard Small-Cap Value ETF
VBR
$37.2B
$9.06M 0.7%
45,717
+5,270
+13% +$1.08M
LEN icon
40
Lennar Class A
LEN
$20.4B
$8.43M 0.65%
63,842
-4,266
-6% -$693K
AZO icon
41
AutoZone
AZO
$51.3B
$6.5M 0.5%
2,030
-310
-13% -$982K
WD icon
42
Walker & Dunlop
WD
$1.73B
$6.35M 0.49%
65,302
-16,277
-20% -$1.76M
MTUM icon
43
iShares MSCI USA Momentum Factor ETF
MTUM
$23.6B
$6.29M 0.49%
30,381
+3,857
+15% +$808K
XOM icon
44
ExxonMobil
XOM
$650B
$6.23M 0.48%
57,901
-3,258
-5% -$381K
UL icon
45
Unilever
UL
$142B
$6.2M 0.48%
97,181
-1,602
-2% -$108K
ICSH icon
46
iShares Ultra Short Duration Bond Active ETF
ICSH
$8.06B
$5.58M 0.43%
110,592
+85,452
+340% +$4.32M
MET icon
47
MetLife
MET
$62.4B
$5.27M 0.41%
64,347
-4,003
-6% -$333K
CVX icon
48
Chevron
CVX
$382B
$4.94M 0.38%
34,095
-1,385
-4% -$212K
BSCS icon
49
Invesco BulletShares 2028 Corporate Bond ETF
BSCS
$3.56B
$4.71M 0.36%
234,126
-26,158
-10% -$531K
VGSH icon
50
Vanguard Short-Term Treasury ETF
VGSH
$29.3B
$4.7M 0.36%
80,788
+39,335
+95% +$2.3M

Similar funds

Shufro Rose & Co's Q4 2024 Portfolio in Review

As of Q4 2024, Shufro Rose & Co held 333 positions worth $1.29B, up 5% from $1.23B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Shufro Rose & Co's Q4 2024 filing shows 17 new, 60 increased, 147 reduced and 33 closed positions. Its largest new stake was ALPS Smith Core Plus Bond ETF: 1,844,088 shares worth $47.1M. The largest sale was iShares iBonds Dec 2027 Term Corporate ETF, an estimated $48.6M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.

  • Shufro Rose & Co's largest Q4 2024 buy was ALPS Smith Core Plus Bond ETF: 1,844,088 shares worth $47.1M.
  • Shufro Rose & Co added most to VanEck Gold Miners ETF in Q4 2024, an estimated $20M increase.
  • Shufro Rose & Co's biggest Q4 2024 reduction was iShares iBonds Dec 2027 Term Corporate ETF, cutting an estimated $48.6M.
  • Shufro Rose & Co fully exited Moderna in Q4 2024, selling an estimated $17.4M.
  • Shufro Rose & Co's ten largest holdings make up 38% of its $1.29B portfolio in Q4 2024.
  • Shufro Rose & Co opened 17 new positions and closed 33 in Q4 2024.
  • Shufro Rose & Co's portfolio value rose 5% quarter-over-quarter to $1.29B.

Based on Shufro Rose & Co's 13F filing for Q4 2024, filed 25 Feb 2025.